Delivery Order SPE2DB22D1002-SPE2DB24FKYP4

Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S, with a ceiling value of $5,391.64 and a completion date of September 27, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Xulane 150-35 MCG/DAY Patches. The contract has a ceiling value of $9,315.81 and an ultimate completion date of December 5, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S, with a ceiling value of $2,107.08 and a completion date of June 3, 2024. The contract is a firm fixed-price type and does not have a set-aside designation. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $14,769.19 and is for the delivery of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S". The contract was awarded on June 24, 2022 with a completion date of June 27, 2022. The contract is a Firm Fixed Price type with no set-aside designation, indicating full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,954.31, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is November 17, 2023. This contract does not have a set-aside designation, indicating it was awarded through full...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,784.02 firm-fixed-price delivery order is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract, valued at $9,977.49, is a firm fixed-price delivery order with an ultimate completion date of September 22, 2022. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Xulane 150-35 mcg/day patch, a contraceptive product, with a ceiling value of $1,691.87 and an ultimate completion date of December 8, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,159.62 for the supply of XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The award has an ultimate completion date of February 29, 2024, and a Firm Fixed Price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,612.44, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FKYP4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" with a ceiling value of $1,789.79. It is a firm-fixed price contract with a period of performance through February 29, 2024.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.

Generated 5/14/25, 10:16 AM